+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy



Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy



Seminars in Cancer Biology 40-41: 192-208



Breast cancer is the most common form of cancer diagnosed in women worldwide and the second leading cause of cancer-related deaths in the USA. Despite the development of newer diagnostic methods, selective as well as targeted chemotherapies and their combinations, surgery, hormonal therapy, radiotherapy, breast cancer recurrence, metastasis and drug resistance are still the major problems for breast cancer. Emerging evidence suggest the existence of cancer stem cells (CSCs), a population of cells with the capacity to self-renew, differentiate and be capable of initiating and sustaining tumor growth. In addition, CSCs are believed to be responsible for cancer recurrence, anticancer drug resistance, and metastasis. Hence, compounds targeting breast CSCs may be better therapeutic agents for treating breast cancer and control recurrence and metastasis. Naturally occurring compounds, mainly phytochemicals have gained immense attention in recent times because of their wide safety profile, ability to target heterogeneous populations of cancer cells as well as CSCs, and their key signaling pathways. Therefore, in the present review article, we summarize our current understanding of breast CSCs and their signaling pathways, and the phytochemicals that affect these cells including curcumin, resveratrol, tea polyphenols (epigallocatechin-3-gallate, epigallocatechin), sulforaphane, genistein, indole-3-carbinol, 3, 3'-di-indolylmethane, vitamin E, retinoic acid, quercetin, parthenolide, triptolide, 6-shogaol, pterostilbene, isoliquiritigenin, celastrol, and koenimbin. These phytochemicals may serve as novel therapeutic agents for breast cancer treatment and future leads for drug development.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058974160

Download citation: RISBibTeXText

PMID: 27609747

DOI: 10.1016/j.semcancer.2016.09.001


Related references

Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment. Anticancer Research 36(11): 5681-5691, 2016

Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling. Oncotarget 6(41): 43375-43394, 2016

Targeting notch signaling and estrogen receptor pathways in human breast cancer stem cells. Journal of Clinical Oncology 26(15_Suppl): 22066-22066, 2016

Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways. European Journal of Nutrition 2018, 2018

Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment. Stem Cells International 2017: 2925869, 2017

Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/β-Catenin Signaling Pathway. Plos One 11(8): E0160836, 2017

Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways. Pharmacology and Therapeutics 158: 71-90, 2016

Targeting the NfB Signaling Pathways for Breast Cancer Prevention and Therapy. Current Medicinal Chemistry 22(2): 264-289, 2014

Cancer signaling pathways with a therapeutic approach: An overview in epigenetic regulations of cancer stem cells. Biomedicine and PharmacoTherapy 108: 590-599, 2018

Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways. International Journal of Molecular Sciences 19(11), 2018

Cancer stem cells and targeting embryonic signaling pathways. Journal of Thoracic Oncology 5(12 Suppl 6): S492-S494, 2011

Targeting the NFκB signaling pathways for breast cancer prevention and therapy. Current Medicinal Chemistry 22(2): 264-289, 2015

Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals. Targeted Oncology 10(3): 337-353, 2016

Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes and Diseases 5(2): 77-106, 2018

Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Research 13(3): 211, 2012